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The interaction of the imlnunosuppr¢~sive complex cyclosporin A-cyclophilin (CsA.CyP) with the Ca-'*/ealmodulin-dependent protein pho~phatas~ 
calcineurin isinvestigated using a recombinat~t form of the A subunit of calelneurin (rCNA). Only in the presence of purified caleineurin B (CNB) 
does rCNA show the response of native calcineurin, i.e. 50% inhibition of rCNA phosphata~e activity at 6 nM human cyelophilin B and 0.6/.tM 
human cyclophilin A using ['~:P]casein as substrate, yet stimulation of activity with p.nitrophenyl phosphate as snbstrate. This study demonstrates 
that the B subunit is necessary to confer sensitivity of c.alcincurin to CsA-CyP, 
Calcineuriu; Cyclosporin A; Cyclophilin; Immunosuppression 
1. INTRODUCTION 
The immunosuppressants eyclosporin A (CsA) and 
FK506 inhibit T-cell activation via a common pathway 
by preventing the transcriptional ctivation of  the inter- 
leukin-2 gene [1-5], These drugs bind to distinct intra- 
cellular receptors, CsA to cyclophilin (CyP) [6,7] and 
FK506 to FK506-binding protein [8,9]. Recently, the 
Caa+/ealmodulin (CaM)-dependent protein phosphat- 
use calcineurin (CN) was implicated as the common 
proximal target of  these drug receptor complexes [10], 
Several studies have since supported this by de- 
monstrat ing that both CsA-Cyp and FKS06-FKBP 
complexes inhibit calcineurin in vitro [10-13], and that 
overexpression of  calcineurin in the T-cell line Jurkat 
resulted in an increased resistance to these drugs [14,15]. 
Calcineurin is a heterodimer comprised of  a 59 kDa 
catalytic A subunit (CNA) and a 19 kDa Ca""-binding 
B subanit (CNB), It is distinguished from other serine/ 
threonine protein phosphatases by the presence of  the 
B subunit, which is required for maximal activity 
[16,17]0 and additional carboxy-terminal domains 
within the A subunit that confer CaM dependence 
[18,19]. From previous work, neither CaM nor the 
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CaM-binding and autoinhibitory domains are neces- 
sary for inhibition by CsA-CyP [l 1,12]. 
In this report the role o f  CNB in the interaction o f  
CN with CsA-CyP is investigated through the use of  a 
recombinant form of  CNA.  It is found that the B sub- 
unit is required to confer sensitivity to CsA-CyP  com- 
plexes. 
2. EXPERIMENTAL 
2.1. En'-yme preparaffon 
Native CN was prepared from bovine brain as described previously 
[20]. The eDNA gene for the tz isoform o1" rat CNA [21,22] was 
obtained as a gift from Drs. B. Perrino and T. Soderling. Recombinant 
CNA (rCNA) was overexpressed in g. coil using a T7 sy~rem and 
purified by a method similar to that for native bovine brain CN [20] 
(Haddy, A,, Swanson, S.K.-H. and Rusnak, F., in preparation). CNB 
was purified from native bovine brain CN by gel filtration chromatog- 
raphy in the presence of SDS [17] and was essentially devoid of phos- 
phatase activity ( <1% of the native enzyme). Recombinant human 
eyclophilin A (hCyPA) [23] and human cyclophilin B (heyPB) [24 l 
were purified from £. coli expression systems provided as gifts from 
Dr. C.T, Walsh. 
2.2, rCNA-CNB reconsli,ttian 
rCNA and CNB were combined in a ratio of approx. 1:2.5 and 
preincubated for 5 rain at 30"C in 50 rnM MOPS, pH 7.0. and 0.5 mM 
CaCI., before addition to assay tubes. For comparison with the activity 
of anrecon~tituted rCNA (Fig. 1), rCNA wa~ similarly ineubat'ed in 
the absence of CNB. 
2.3. [~"PjCazein assciys 
[~:PlCa~in was prepared a5 described [25] by phosphorylation f
casein (Sigma) using cAMP-dependent protell~ klnase catalytic sub- 
unit (Sigma). Assays using [~-'P]easein as substrate were performed in 
50 mM MOPS, pH 7.0, 1.0 mg/ml BSA, 0.5 ram DTf and 1,0 mM 
CoOl2, MnCI:, CaM, CsA, heyPA and hCyPB were added as indi- 
cated. After addition fCN. leNA, and/or CNta, the assay tubes were 
preincubated for 10 rain at 30"C. Reactions were initiated by [3'P~a- 
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sein addition and allowed to proceed for 10 min at 30°C belbre 
quenchir,~ wi~h tri¢%r~a~.~.ic acid and BSA as de~crlbed i2S]. 
2.4, /;N6t ° assays 
As.,ays usi{~g p-nitroo[teayl Olto~gltate (gNPP) as su~teate ¢¢eee 
performed in 25 mM MOPS, pH ?.0, 1.0 mM CaC].,, ] .0 mM MaUl, 
and 0.40/.tM CaM at room temperature (23°C). CsA and hCyPA or 
hCyPB were added as indicated, Alter addition of rCNA or rCNA- 
CNB the solution was preineubated for 15 rain at 37~C before initia- 
tion cg(:/te reac(io~ 6¥ (tke ttd<i(~.(~at~ ,a(" 9NPq' t~ ~. (ivy.( ¢,a~¢¢~x~.~.(c,~x 
of l0 raM. The absorbance hange at 405 nm was monitored using a 
miemttter plate reader, 
$andoz, was prepared in 50% ethanol. A 50 AiM solution used lot 
addition to the assay tubes was prepared from ~h¢ 5 mM slogk by ~eria] 
dilution with distilled water, hCyPA and hCyPB stock solutions were 
diluted to appropriate stock solutions in 50 mM MOPS, pH 7.0. CsA, 
hCyPA and hCyPB were added to the assay tubes after all other 
components except for caleineurin, 
40'  
• rCNA+CNB 
• ('C~R o(~(y 
100% 
IS.3% 
~z. 0.1% 1].2% 
a ~ 1 . 9 %  0.2% 
no aOdn +CaM +Mn(ll) +CaM,Mn(II) 
the presence and absence of CaM and MnCI:: solid bars, rCNA alon~; 
shaded bars, rCNA reeo~titate.tt vcitix CNB. A~a~ 'we're 9erformed 
fn the presence ofgI nM rC~A alone or 20 nM rCNA plus 35 nM 
CNB and 0.67 pM [~:P]casein. When present he concentrations of 
CaM and MnCI: were 0.58/~M and 1.0 raM, respectively, %activity 
is defined as the activity relative to that of rCNA-CNB in the presence 
of CaM and MnCI.,, which showed a specific activity of 28 
stool, rain -t. mg rCNA -~. 
3. RESULTS 
Recombinant caleineurin A (rCNA) was purified 
from an E. coil overexpression system and was therefore 
this manner included a 10 residue fusion sequence with 
the bacteriophage T7 gene 10 protein [26]. The eDNA 
for this protein corresponded to a rat ~x isoform that 
lacked the polyproline sequence at the N-terminus and 
a 10 amino acid sequence at the C-terminus [21]. 
Phosphatase activity was assessed using [~2P]case[n 
catalytic subunit, a commonly used calcineurin sub- 
strate ]25,2'7) with which J~ative CN shows lhe same 
inhibition by CsA-CyP as it does with [Ser(~-'P)t~R], 
peptide [I1]. The phosphatase activity of rCNA was 
very low, only 1-3 nmol. min -~ .rag rCNA -~ in the pres- 
ence of calmodulin (CAM) and MnCI,, compared with 
100--150 nmol min -~ .mg CN -~ for native bovine brain 
ealcineurin (CN) under the same conditions. Addition 
of C'N'i~ pa-r:t~e6 from bovine bra'm "I.WI to rC'NA in flxe 
presence of CaM and Mn -~" led to an increase in phos- 
phatase activity to 25-35 nmol min-~ .rag rCNA -~. The 
increase in specific activity of rCNA reconstituted with 
CNB (rCNA.CNB) to a level comparable to that of 
native CN (25%) indicates that a considerable portion 
of functional native-like rCNA-CNB molecules were 
formed. 
similar esponses to the efth:tors Mn a* ~oA C~M. [a ~l~e 
absence of CNB, the activity of rCNA was stimulated 
4-fold hy CaM, lS-fo~d lay MnC[,., and 4~3-fotd by bo~.h. 
Similarly, in the presence of CNB, rCNA activity was 
stimulated 4-fold by CaM, 8-fold by MnCI~ and 50-fold 
by both (Fig. 1). Native CN is also stimulated by either 
CaM or MnCh and manyfold more by both depending 
on the preparation [27,28]; the preparation used for 
theme ~r~e, dvz~,wes i'e,a~ ,e ~,~,'~" ,,%at"grt,~'axf a~qgfi~ tYra¢ 
was stimulated about 25-fold by CaM, 21-fold by 
MnCI,_ and 185-fold by both. The similarity of native 
and recombinant calcineurin (with and without CNB) 
properties are conferred by the catalytic subunit, as 
noted previously [16-19]. In addition, rCNA (without 
CNB) and native CN showed similar responses to the 
inorganic inhibitors PO43- and MO,~- (data not shown). 
For comparison of the inhibition of rCNA and rCNA- 
CNB by CsA-CyP, both MnCI: and CaM were included 
rates, as in previous tudies [22]. 
The i~hibition of rCNA aeti vity CsA-CyP was tested 
in the absence and presence of CNB using [3"~P]casein as 
substrate. Inhibition ot" native CN requires both CsA 
and CyP [10,11], although some inhibition ( < 25%) is 
observed with pM amounts of human cyclophilin B 
(hCyPB) alone. In the absence of CNB, rCNA was not 
inhibited by 1.3 ].tM human cyclophilin A fhCyPA) el- 
fixer alone or in combination with CsA, while 0.93 pM 
hCyPB caused only minor inhibition (25-30%) regard- 
less of whether CsA was present (Table I). In contrast, 
rCNA reconstituted with CNB behaved like native CN 
in that it was inhibited by both CsA-hCyPB and CsA- 
hCyPA but not by CsA, hCyPA or hCyPB alone. Al- 
though rCNA-CNB was not completely inhibited by 1 
~M CsA-hCyPA (,37% activity remained), its activity 
~'~,~¢?d 3,¢/'erNr,.or'eccFFreeeed ueirfE /r/Jrec ¢ocrt."eaere~tfoa~" 
~3fCsA-kQtPA ~see F~. 2A}. Th~ ~e~ult~ indicate 1.hat 
calcineurin B is an essential component for conferring 
sensitivity to the drug-receptor complexes. It is also 
notable that the rCNA isoform used here lacks the pol- 
yproline region [18,21], indicating that this region is not 
important for binding of CsA-CyP. 
To further demonstrate he requirement for CNB to 
reconstitute a native-like response to CsA-CyP, the 
phospfiamse acffvffy reward p-nftropfienyf pfiuspfiate 
38 
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(pNPP) was tested in the presence of the complexes. 
With pNPP, the immunosuppressive complexes actually 
stimulated the activity of native CN by 3- to 4.fold 
[IO, l I], Similar/~ rCNA showed a 2-fold stimalatiort of 
aclivity by CsA-hCyPB or CsA-hCyPA only when re- 
constituted with CNB (Table I). 
rCNA reconstituted with CNB showed nearly identi- 
cal sensitivity as native CN to CsA-hCFPA and CsA- 
hCyPB using [~P]casein as substrate. The concentration 
of CsA-CyP necessary for 50% inhibition (ICs0) of 
rCNA-CNB was found to be 6 nM for CsA-hCyPB and 
inhibitors, IC~o must be equal to or greater than the 
enzyme concentration [1 IJ. Hence the comparison of  
IC~o for CsA-hCyPB (5 nM) with the assay concentra- 
tion ofcalcineurin (26 riM) must reflect he presence of" 
25-30% Rmctional rCNA-CNB0 as suggested by com- 
parison of its specific activity with native CN noted 
above. ICs0s for rCNA-CNB are close to the values for 
native CN of 10 nM for CsA-hCyPB and 1 /zM tbr 
CsA-hCyPA under the same assay conditions (Fig. 2B). 
4. DISCUSSION 
This study shows that inhibition of calcineurin by 
CsA-CyP is dependent upon the presence of calcineurin 
Table I 
Effect of calcineurin B on the sensitivit2~ ~frecombinant caicineurin 
clophilin B 
Conditions ~ % activity 
rCNA (%) rCNA-CNB (%) 
[~-~Plcasein as substrate~': 
no addition 100.0 ~ 100.0 a
÷ CsA 90.7 96.8 
+ hCyPA 96.2 96.9 
+ CsA, hCyPA 88.3 37.2 ~ 
+ hCyPB 72.8 79.8 
+ CsA, hCyPB 75.4 2.6 
pNPP as substrag¢h 
no addition 100.0 100.0 
• .~ CsA, hCyPA 86.0 193.0 
+ CsA, hCyPB 115.0 213.0 
Lff, f.L and 0".':5 m~, respected/ely. 
of 1.0 mM MnCl_, and 0.58 mM CaM using either 92 nM rCNA alone 
or 25 nM rCNA plus 60 nM CNB, and 0,85-1.6 tam ~"P]casein. 
Assays using oNPP were performed using either 460 nM rCNA 
alone, 63 nM rCNA plus 150 nM CNB 
d 100% activity is defined as th~ activity in the absence of CsA, hCyPA 
or hCyPB lbr each column. Each ,% activity value is the average of 
2 or 4 measurements. 
This % activity was obtained using a concentration f hCyPA close 
at higher concentrations f CsA-hCyPA. 
A 
7 i "i 
o 
%, . . . . . . . . . . . .  . 
10"2 1(~ "~ "tO o 1Q ~ I0  ;~ 10 ~ 10 4 10 = 
B 
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Fig. 2. Inhibition of calcincurin by CsA-hCyPA (open circles) and 
CsA-hCyPB (closed circles): A, reconstituted rCNA-CNB; B, native 
bovine brain CN. For rCNA-CNB, [~-'P]casein assays were performed 
in lhe presence of 1.0 mM MnCI,, 0.58/aM CaM, 0.75-2.0,uM [~-'Plea- 
peribrmed inthe presence of 1.0 mM MnCG, 0.40 #M CaM, 0.$-0.75 
#M [)'-Pl, casein and 5-10 nM CN. The final concentnttion f CsA was 
either I t:¢M, equal to the canceaWai~.oa oFhC£PA when the latter ~as 
greater than 1 #M, or 0.4 :tM when the concentration f hCyPB was 
les~ than I~3 riM. Each erro~ bat repr~g-nx~ lh~ ~ianda~d d~vialioa of 
the value, for which 2, 4 or 6 measttremems were averaged. 
B. This is demonstrated by the observation that rCNA 
activity in the absence of the B subunit, although lower 
in general, is not inhibited by the drug-receptor com- 
plex. This suggests that CNB somehow endows CN 
with the requisite molecular structure for interaction 
with the immunosuppressant drugs CsA and FKb06. 
From the data presented here it is not clear whether 
CNB creates or stabilizes the binding site for CsA-Cyp 
on CNA or whether CNB itself interacts partially with 
C~,4-C:P. S:~rce FKS, M'-FK,gP ?e~ ~e¢,¢ /'Qcaed ¢hees :~: 
t~ act by ih~ sarr~ ~lit~ as CsA-CyP, ii ,,v~Bkl be er,- 
petted to show a similar dependence on the B subunit 
t'or inhibition ol" the phosphatase activity of native Cbi. 
IVln 2"- has long been known to have a stimulatory 
effect on calcineurin. Indeed, it is shown here that Mn :+ 
stimulates rCNA activity in the presence or absence of 
CNB. Although it has been suggested that CN has a 
specific site for Mn 2~ [29], immunoprecipitation experi- 
ments flare been unable fo de'mon~raee ~  pre~eac~ of' 
39 
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endogenous Mn [30]. Interestingly, CN does not display 
Mn 2. dependence prior to affinity purification on CaM- 
Sepharose [31]. In the experiments performed here, we 
have included MnCh_ in the buffer system in order to 
raise the activity of rCNA above its low basal level. The 
inhibitory effect of the vesicular isofonn of cyclophilin, 
CyPB, on native CN is essentially the same whether or 
not Mn -~+ is present. Inhibition of native CN by the 
cytoplasmic isoform, CyPA, has been previously found 
to occur at a lower concentration (ICs0 = 40 nM [11,12]) 
than observed here, with the difference possibly due to 
the use of MnCI~ in these assays. 
Although it is generally accepted that the functional 
unit ofcalcineurin comprises both CNA and CNB, little 
is known about the precise role of  CNB in rive other 
than that it conveys full activity to the catalytic subunit. 
The need for a regulatory B subunit has been unclear 
because calmodulin has the function of controlling cal- 
cineurin through cell signalling pathways. Furthermore, 
other serine/threonine protein phosphatases (PPI, 
PP2A and PP2C) do not require a CNB-like subunit for 
activity or in vivo regulation 1"28,32]. Recently a distinct 
isoform of CNB was discovered from rat testis [33], 
opening up the possibility that other tissue specific 
isoforms of CNB also exist. This suggests that distinct 
isoforms ofeither CNA or CNB may control the prefer- 
ence of the immunosuppressive drugs for action specif- 
ically on T-cells. Future studies aimed at investigating 
the interaction of caleineurin with immtmophilins must 
consider the role CNB plays in the formation of the 
calcineurin-immunophilin complex. 
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